What to expect when being treated with NarvalTM CC ?
This small, custom-made device is designed to support your treatment of obstructive sleep apnoea1–3.
The article walks you through what to expect from your treatment, including early benefits and mild side effects during the adaptation phase.
What if change started today?
If you are using a Narval CC device to treat your obstructive sleep apnoea (OSA) or snoring, you are taking an important step toward better sleep and improved well-being. This custom-made device may be small, but it can play a meaningful role in your treatment1.
With consistent use, you may notice improvements such as2:
- Reduced snoring
- Improved daytime alertness
- Better sleep quality
To help build the habit, try placing your Narval CC on your nightstand, right where you’ll see it every night.
What about side effects?
Like any treatment, Narval CC can come with some side effects, especially during the adaptation phase. Most are mild and temporary, such as1:
- Jaw or muscle discomfort
- Dry mouth or extra saliva
- Temporary bite changes
- Tooth movement or dental changes may also happen over time
These effects are typically manageable, and most patients adjust within a few weeks1.
Follow-up visits with your dental practitioner are key to identifying and addressing any issues early on5,6.
Follow-up visits with your dentist are essential to identify and address any issues as soon as they arise5,6.
Be sure to see your dentist regularly.
Legal Mentions
PROMOTIONAL MATERIAL – Narval CC is compliant with applicable regulations.Manufacturer: Resmed.Local contact: Resmed. Please refer to the instructions for use for relevant information related to any contraindications, warnings and precautions.1036799/1 06/26
References
- Vecchierini MF, Attali V, Collet JM, et al. Mandibular advancement device use in obstructive sleep apnea: ORCADES study 5-year follow-up data. J Clin Sleep Med JCSM Off Publ Am Acad Sleep Med. 2021;17(8):1695-1705. doi:10.5664/jcsm.9308
- Vecchierini MF, Attali V, Collet JM, et al. A custom-made mandibular repositioning device for obstructive sleep apnoea–hypopnoea syndrome: the ORCADES study. Sleep Med. 2016;19:131-140. doi:10.1016/j.sleep.2015.05.020
- Attali et al. Efficacy and tolerability of a custom-made Narval mandibular repositioning device for the treatment of obstructive sleep apnea: ORCADES study 2-year follow-up data. Sleep Med. 2019;63. doi:10.1016/j.sleep.2019.04.021
- Kazemeini E, Op De Beeck S, Vroegop A, et al. A pilot study on comparison of subjective titration versus remotely controlled mandibular positioning during polysomnography and drug-induced sleep endoscopy, to determine the effective protrusive position for mandibular advancement device therapy. Sleep Breath. 2022;26(4):1837-1845. doi:10.1007/s11325-022-02569-3
- Ramar K, Dort LC, Katz SG, et al. Clinical Practice Guideline for the Treatment of Obstructive Sleep Apnea and Snoring with Oral Appliance Therapy: An Update for 2015: An American Academy of Sleep Medicine and American Academy of Dental Sleep Medicine Clinical Practice Guideline. J Clin Sleep Med. 2015;11(7):773-827. doi:10.5664/jcsm.4858
- Yu M, Ma Y, Han F, Gao X. Long-term efficacy of mandibular advancement devices in the treatment of adult obstructive sleep apnea: A systematic review and meta-analysis. PLOS ONE. 2023;18(11):e0292832. doi:10.1371/journal.pone.0292832